Compare Danaher Corporation (DHR) vs Oracle Corporation (ORCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Oracle Corporation — how do they compare? Danaher Corporation trades at $197.72 (market cap $140.88B), while Oracle Corporation trades at $129.15 (market cap $368.53B). The key difference: Oracle Corporation is far larger — about 2.6× Danaher Corporation's market cap, and Oracle Corporation pays the higher dividend (1.56%). Which is the better fit depends on your goals.
| DHR | ORCL | |
|---|---|---|
Market Cap | $140.88B | $368.53B |
Sector | Health | Technology |
52-Week High | $242.05 | $328.33 |
52-Week Low | $161.91 | $127.96 |
Enterprise Value | $153.66B | $497.78B |
Dividend Yield | 0.8% | 1.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $199.05, showing minimal daily change, with a bullish technical signal supported by moving averages. The company maintains strong profitability with a 58.94% gross margin and has beaten earnings estimates for the last three quarters. Recent news highlights the acquisition of Masimo and new product launches in its SCIEX division, indicating growth initiatives. Cash flow improved in 2025 to a net inflow of $2.54 billion, though revenue growth remains modest.
The outlook is positive with a consensus price target of $211.33, representing a 6% upside, and 69% of analysts rate it a buy. Risks include slowing revenue growth, high valuation multiples, and integration challenges from acquisitions. The stock offers a dividend yield supported by stable cash flows, but investors should monitor competitive pressures in the life sciences sector.
Oracle Corporation (ORCL) is trading at $127.96, down 9.04% today, reflecting recent market volatility. The stock shows strong fundamentals with consistent earnings beats (Q1 2026 EPS of $2.11 vs. $1.96 expected) and robust profitability (net margin of 25.37%). Technical indicators are bearish with support at $124, while analyst consensus remains bullish with a $259 price target. Recent news highlights Oracle's AI infrastructure expansion and partnership with OpenAI.
Outlook: Oracle's AI-driven growth and solid financials support long-term upside, but near-term risks include high debt levels and competitive pressures. The stock offers value for investors seeking exposure to enterprise software and cloud infrastructure, with earnings on June 10, 2026, as a key catalyst.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Oracle Corporation
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
Read more on ORCL →
